Just one week left to book FREE 2025 Annual Patient Information Day tickets! Central London, Saturday 31st May. Check out our website for programme and bookings.
www.amend.org.uk/patients/sup...
#MEN1 #MEN2 #MEN2A #MEN2B #PPGL #phaeopara #pheopara #ACC #adrenocorticalcancer #patientinformation
www.amend.org.uk/patients/sup...
#MEN1 #MEN2 #MEN2A #MEN2B #PPGL #phaeopara #pheopara #ACC #adrenocorticalcancer #patientinformation
May 7, 2025 at 1:05 PM
Everybody can reply
💚 We would like to introduce the new ACC Support UK website which is now; ▶️ Easier to navigate, ♿️ More accessible, ℹ Contains info on adrenal tumours in children. Thanks to the family/friends of the late Sally Zelenczuk for making this possible. 📲 accsupport.org.uk
#adrenocorticalcancer #ACC
#adrenocorticalcancer #ACC
April 28, 2025 at 2:32 PM
Everybody can reply
Jo (MEM2A) and Gill (MEN1) from AMEND are here and happy to speak with you. Let us show you how we help your patients. #sfeBES2025 @socendocrinology.bsky.social #multipleendocrineneoplasia #paraganglioma #adrenocorticalcancer
March 10, 2025 at 2:08 PM
Everybody can reply
1 reposts
3 likes
🌍 Today is #RareDiseaseDay
Adrenocortical cancer affects just 1–2 per million, making research and treatment development challenging. But rare shouldn’t mean forgotten! ACC research is key to better treatments. Let’s keep pushing forward!
#AdrenocorticalCancer #RareButImportant
Adrenocortical cancer affects just 1–2 per million, making research and treatment development challenging. But rare shouldn’t mean forgotten! ACC research is key to better treatments. Let’s keep pushing forward!
#AdrenocorticalCancer #RareButImportant
February 28, 2025 at 4:07 PM
Everybody can reply
3 likes
🆕🗞️A new piece of evidence "against" in a debatted subject : adjuvant radiation therapy in adrenal cancer 👇👇👇
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Adjuvant radiation therapy is not associated with a survival benefit after R0 resection in non-metastatic adrenocortical carcinoma
The benefit of adjuvant radiation therapy (RT) in adrenocortical carcinoma (ACC) is not well characterized for those who undergo initial R0 surgical r…
www.sciencedirect.com
January 27, 2025 at 8:19 AM
Everybody can reply
Membership of AMEND is free to anyone affected by MEN or PPGL syndromes, MTC and ACC, as well as to health professionals: www.amend.org.uk/patients/joi...
#MEN1 #MEN2 #MEN3 #MEN2A #MEN2B #PPGL #paraganglioma #phaeochromocytoma #Adrenocorticalcancer #ACC #MTC #medullarythyroidancer
#MEN1 #MEN2 #MEN3 #MEN2A #MEN2B #PPGL #paraganglioma #phaeochromocytoma #Adrenocorticalcancer #ACC #MTC #medullarythyroidancer
January 22, 2025 at 2:03 PM
Everybody can reply
1 reposts
1 likes
Clinical trial researching neuroendocrine neoplasms | Center for Cancer Research
A clinical trial led by Jaydira Del Rivero, M.D., Associate Research Physician in the Developmental Therapeutics Branch, is researching the biology of neuroendocrine neoplasms.
ccr.cancer.gov
January 21, 2025 at 2:14 PM
Everybody can reply